Paper18560412
Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.
Bonanomi S and 10 others. Bone Marrow Transplant, 2008. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy. Papers, record 18560412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18560412
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Stem Cell Transplantation | Major topic |
| Transplantation Conditioning | Major topic |
| Alemtuzumab | |
| Antibodies, Monoclonal | |
| Antibodies, Monoclonal, Humanized | |
| Antibodies, Neoplasm | |
| Busulfan | |
| Child | |
| Child, Preschool | |
| Combined Modality Therapy | |
| Cyclophosphamide | |
| Cyclosporine | |
| Female | |
| Graft vs Host Disease | |
| Humans | |
| Immunotherapy | |
| Infant | |
| Male | |
| Melphalan | |
| Transplantation Chimera | |
| Transplantation, Homologous |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14751924 | Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. | Blood | 2004 | https://conductscience.org/library/papers/14751924 | PubMed |
| 2 | 14662323 | Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned? | Exp Hematol | 2003 | https://conductscience.org/library/papers/14662323 | PubMed |
| 3 | 17374741 | Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. | Blood | 2007 | https://conductscience.org/library/papers/17374741 | PubMed |
| 4 | 16304572 | Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. | Leukemia | 2005 | https://conductscience.org/library/papers/16304572 | PubMed |
| 5 | 8201385 | Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle. | J Clin Oncol | 1994 | https://conductscience.org/library/papers/8201385 | PubMed |
| 6 | 16155933 | Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome. | Pediatr Blood Cancer | 2006 | https://conductscience.org/library/papers/16155933 | PubMed |
| 7 | 11133742 | A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. | Blood | 2001 | https://conductscience.org/library/papers/11133742 | PubMed |
| 8 | 14990984 | Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. | Bone Marrow Transplant | 2004 | https://conductscience.org/library/papers/14990984 | PubMed |
| 9 | 16878146 | Final height and gonad function after total body irradiation during childhood. | Bone Marrow Transplant | 2006 | https://conductscience.org/library/papers/16878146 | PubMed |
| 10 | 15367433 | Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. | Blood | 2005 | https://conductscience.org/library/papers/15367433 | PubMed |
| 11 | 16425264 | The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen. | Pediatr Blood Cancer | 2006 | https://conductscience.org/library/papers/16425264 | PubMed |
| 12 | 17278259 | Improved outcome after relapse in children with acute myeloid leukaemia. | Br J Haematol | 2007 | https://conductscience.org/library/papers/17278259 | PubMed |
| 13 | 9384480 | Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants. | Bone Marrow Transplant | 1997 | https://conductscience.org/library/papers/9384480 | PubMed |
| 14 | 7606014 | Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. | Blood | 1995 | https://conductscience.org/library/papers/7606014 | PubMed |
| 15 | 12393725 | Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. | Blood | 2003 | https://conductscience.org/library/papers/12393725 | PubMed |
| 16 | 9359499 | Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission. | Br J Haematol | 1997 | https://conductscience.org/library/papers/9359499 | PubMed |
| 17 | 2668871 | Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. | Percept Mot Skills | 1989 | https://conductscience.org/library/papers/2668871 | PubMed |
| 18 | 15937497 | Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia? | Bone Marrow Transplant | 2005 | https://conductscience.org/library/papers/15937497 | PubMed |
| 19 | 4153799 | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. | Transplantation | 1974 | https://conductscience.org/library/papers/4153799 | PubMed |
| 20 | 15353481 | Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. | Blood | 2005 | https://conductscience.org/library/papers/15353481 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28218757 | Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience. | Bone Marrow Transplant | 2017 | https://conductscience.org/library/papers/28218757 | PubMed |
| 19947897 | Immune-based therapeutics for pediatric cancer. | Expert Opin Biol Ther | 2010 | https://conductscience.org/library/papers/19947897 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18560412
GET https://conductscience.org/api/papers/v1/18560412/references?page=2